Real-world evidence
All the latest
Showing 9 of 0 results
- PFS as a surrogate endpoint for OS in real-world patients with ROS1+ advNSCLC in the United States
World Conference of Lung Cancer
- Real-world characteristics and distant metastasis free survival of patients with early NSCLC treated with chemoimmunotherapy
World Conference of Lung Cancer